Erectile dysfunction (ED) is common and impacts psychosocial wellbeing negatively. Many do not seek medical attention and several barriers for healthcare seeking with ED exist. Little is known about the association between socioeconomic characteristics of the patient and barriers for healthcare-seeking for men bothered by ED.
Lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is a common condition affecting older men. New interventional treatments have emerged and evolved over the years, each with their own distinct efficacy and safety profiles.
Benign prostatic hyperplasia (BPH) is a disease of the urinary system. It is common in middle-aged and elderly men. Moxibustion is widely used to manage BPH and the associated lower urinary tract symptoms, but there is still lack of systematic review of moxibusiton for BPH.
To analyze the potential surgical factors affecting postoperative urinary continence, including postoperative membranous urethral length (MUL), in an era where open radical prostatectomy (ORP) and robot-assisted radical prostatectomy (RARP) coexist.
Reduced port laparoscopic radical nephrectomy (RPLRN) is an equivalent approach to conventional laparoscopic radical nephrectomy (LRN). In LRN, one wound generally needs to be extended for specimen extraction; therefore, some ingenuity is needed to achieve a good cosmetic outcome.
OBJECTIVE. The purpose of this study was to investigate the diagnostic performance of semiquantitative and quantitative pharmacokinetic parameters and quantitative apparent diffusion coefficient (ADC) values obtained from prostate multiparametric MRI (mpMRI) to differentiate prostate cancer (PCa) and prostatitis objectively.
San Francisco, CA (UroToday.com) — The Bladder Cancer Advocacy Network (BCAN) was saddened to learn of the bladder cancer diagnosis of professional golfer John Daly. According to an interview with the Golf Channel, Mr. Daly stated that he had recently been suffering from back pains and said these issues caused him to see his doctor.
In a change for uro-oncology experts across Europe, the 12th European Multidisciplinary Congress on Urological Cancers (EMUC20) is now a two-day virtual congress. While the organisers had hoped that the EMUC congress could be held physically like every year, the ongoing pandemic has led to a switch to an online, virtual EMUC for 2020. EMUC is […]
Highlights We found 25% ORR in pre-chemotherapy cohort 1 and 10% ORR in post-chemotherapy cohort 2 We report 5.5 and 3.8 months median rPFS and 19.0 and 15.2 months median OS Exploratory analyses identify potential biomarkers of response Study expansion is needed to assess other dosing regimens Summary Metastatic castration-resistant prostate cancer (mCRPC) is immunologically “cold” and […]
Phase II trial provides rationale for pursuing further study of dual checkpoint blockade San Francisco, CA (UroToday.com) — Results from a Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center suggest that a combination of ipilimumab (anti-CTLA-4) plus nivolumab (anti-PD-1) can generate durable responses in a subset of patients with metastatic castration-resistant prostate […]
